Table 4. List of up-regulated and down-regulated pathways in β-thalassemia patients in comparison to healthy controls.
Pathway Name | Total Compound Present in Pathway | Hits | Raw p | −log(p) | Holm p | FDR | Impact |
---|---|---|---|---|---|---|---|
Up-regulated: | |||||||
Fatty acid elongation in mitochondria | 27 | 1 | 0.0967 | 2.3362 | 1 | 1 | 0 |
Glycolysis or Gluconeogenesis | 31 | 1 | 0.11029 | 2.2046 | 1 | 1 | 0 |
Pyruvate metabolism | 32 | 1 | 0.11366 | 2.1745 | 1 | 1 | 0.13756 |
Propanoate metabolism | 35 | 1 | 0.1237 | 2.0899 | 1 | 1 | 0 |
Glycerophospholipid metabolism | 39 | 1 | 0.13694 | 1.9882 | 1 | 1 | 0 |
Galactose metabolism | 41 | 1 | 0.14348 | 1.9415 | 1 | 1 | 0.01716 |
Fatty acid biosynthesis | 49 | 1 | 0.16924 | 1.7764 | 1 | 1 | 0 |
Fatty acid metabolism | 50 | 1 | 0.17241 | 1.7579 | 1 | 1 | 0.02959 |
Starch and sucrose metabolism | 50 | 1 | 0.17241 | 1.7579 | 1 | 1 | 0.05947 |
Down-regulated: | |||||||
Glycerolipid metabolism | 32 | 1 | 0.064781 | 2.7367 | 1 | 1 | 0.18847 |
Galactose metabolism | 41 | 1 | 0.082382 | 2.4964 | 1 | 1 | 0 |
Fatty acid biosynthesis | 49 | 1 | 0.097804 | 2.3248 | 1 | 1 | 0 |
Glyoxylate and dicarboxylate metabolism | 50 | 1 | 0.099717 | 2.3054 | 1 | 1 | 0 |